The vascular hypothesis of Alzheimer's disease: Bench to bedside and beyond

Neurodegenerative Diseases

Volumn 7, Issue 1-3, 2010, Pages 116-121

  De La Torre, Jack C ^a  

^a SUN HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

Cardiovascular disease; Carotid artery stenosis; Carotid artery ultrasound; Cerebral hypoperfusion; Echocardiography; Intima media thickness; Vascular hypothesis of Alzheimer's disease

Indexed keywords

AGING; ALZHEIMER DISEASE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY DISEASE; COGNITIVE DEFECT; CONFERENCE PAPER; DISEASE SEVERITY; ECHOCARDIOGRAPHY; HUMAN; MIDDLE AGED; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; ULTRASOUND;

ALZHEIMER DISEASE; ECHOCARDIOGRAPHY; HUMANS; MODELS, BIOLOGICAL; RISK FACTORS; ULTRASONOGRAPHY, DOPPLER; VASCULAR DISEASES;

EID: 76749115241     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000285520     Document Type: Conference Paper

References (45)

1. Alzheimer's Association: 2009 Alzheimer's disease facts and figures. Alzheimers Dement 2009; 5: 234-270.
2. de la Torre JC, Mussivand T: Can disturbed brain microcirculation cause Alzheimer's disease? Neurol Res 1993; 15: 146-153.
3. Caselli RJ, Chen K, Lee W, Alexander GE, Reiman EM: Correlating cerebral hypometabolism with future memory decline in subsequent converters to amnestic pre-mild cognitive impairment. Arch Neurol 2008; 65: 1231-1236.
4. Roher AE, Esh C, Kokjohn TA, Kalbak W, Luhers DC, Seward JD, Sue LI, Beach TG: Circle of Willis atherosclerosis is a risk factor for sporadic Alzheimer's disease. Arterioscler Thromb Vasc Biol 2003; 23: 2055-2062.
5. Milionis HJ, Florentin M, Giannopoulos S: Metabolic syndrome and Alzheimer's disease: a link to a vascular hypothesis? CNS Spectr 2008; 13: 606-613.
6. Helzner E, Luchsinger J, Scarmeas N, Cosentino S, Brickman A, Glymour M, Stern Y: Contribution of vascular risk factors to the progression in Alzheimer disease. Arch Neurol 2009; 66: 343-348.
7. Aguero-Torres H, Kivipelto M, von Strauss E: Rethinking the dementia diagnoses in a population-based study: what is Alzheimer's disease and what is vascular dementia? A study from the Kungsholmen project. Dement Geriatr Cogn Disord 2006; 22: 244-249.
8. Breteler MM: Vascular risk factors for Alzheimer's disease: an epidemiological study. Neurobiol Aging 2000; 21: 153-160.
9. Dede DS, Yavuz B, Yavuz BB, Cankurtaran M, Halil M, Ulger Z, Cankurtaran ES, Aytemir K, Kabakci G, Ariogul S: Assessment of endothelial function in Alzheimer's disease: is Alzheimer's disease a vascular disease? J Am Geriatr Soc 2007; 55: 1613-1617.
10. Beach TG, Wilson JR, Sue LI, Newell A, Poston M, Cisneros R, Pandya Y, Esh C, Connor DJ, Sabbagh M, Walker DG, Roher AE: Circle of Willis atherosclerosis: association with Alzheimer's disease, neuritic plaques and neurofibrillary tangles. Acta Neuropathol 2007; 113: 13-21.
11. Ruitenberg A, den Heiker T, Bakker SL: Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam study. Ann Neurol 2005; 57: 789-794.
12. Lindsay J, Laurin D, Verreault R, et al: Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging. Am J Epidemiol 2002; 156: 445-453.
13. de la Torre JC: How do heart disease and stroke become risk factors for Alzheimer's disease? Neurol Res 2006; 28: 637-644.
14. de la Torre JC, Cada A, Nelson N, Davis G, Sutherland RJ, Gonzalez-Lima F: Reduced cytochrome oxidase and memory dysfunction after chronic brain ischemia in aged rats. Neurosci Lett 1997; 223: 165-168.
15. de la Torre JC: Impaired brain microcirculation may trigger Alzheimer's disease. Neurosci Behav Rev 1994; 18: 397-401.
16. Hofman A, Breteler MM, Bots ML, Slooter AJ, van Harskamp F: Atherosclerosis, apolipoprotein E and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet 1997; 349: 151-154. (Pubitemid 27039193)
17. Casserly I, Topol E: Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins. Lancet 2004; 363: 1139-1146.
18. van Oijen M, de Jong FJ, Witteman JC, Hofman A, Koudstaal PJ, Breteler MM: Atherosclerosis and risk for dementia. Ann Neurol 2007; 61: 403-410.
19. de la Torre JC: Is Alzheimer's a neurodegenerative or a vascular disorder? Data, dogma and dialectics. Lancet Neurol 2004; 3: 184-190.
20. Whitmer RA, Sidney S, Selby J, Johnston SC, Yaffe K: Midlife cardiovascular risk factors and risk of dementia in late life. Neurology 2005; 64: 277-281.
21. Kilander L, Andren B, Nyman H, Lind L, Boberg M, Lithell H: Atrial fibrillation is an independent determinant of low cognitive function: a cross-sectional study in elderly men. Stroke 1998; 29: 1816-1820.
22. Zuccalà G, Cattel C, Manes-Gravina E, Di Niro MG, Cocchi A, Bernabei R: Left ventricular dysfunction: a clue to cognitive impairment in older patients with heart failure. J Neurol Neurosurg Psychiatry 1997; 3: 509-512.
23. de la Torre JC: Alzheimer's disease prevalence can be lowered with non-invasive testing. J Alzheimers Dis 2008; 14: 353-359.
24. de la Torre JC: Carotid artery ultrasound and echocardiography (CAUSE) testing to lower the prevalence of Alzheimer's disease. J Stroke Cerebrovasc Dis 2009; 18: 319-328.
25. de la Torre JC, Fortin T, Park G, Butler K, Kozlowski P, Pappas B, de Socarraz H, Saunders J, Richard M: Chronic cerebrovascular insufficiency induces dementia-like deficits in aged rats. Brain Res 1992; 582: 186-195.
26. de la Torre JC, Fortin T, Park Saunders J, Kozlowski P, Butler K, de Socarraz H, Pappas B, Richard M: Aged but not young rats develop metabolic, memory deficits after chronic brain ischemia. Neurol Res 1992; 14(suppl):177-180.
27. de la Torre JC, Fortin T, Park G, Pappas B, Saunders J, Richard M: Brain blood-flow restoration 'rescues' chronically damaged rat CA1 neurons. Brain Res 1993; 623: 6-15.
28. de la Torre JC, Pappas BA, Fortin T, Keyes M, Davidson C: Progressive neurodegeneration in rat brain after chronic 3-VO or 2-VO; in Fiskum G (ed): Neurodegenerative Diseases. New York, Plenum Press, pp 77-84, 1996.
29. Matsuda H: The role of neuroimaging in mild cognitive impairment. Neuropathology 2007; 27: 570-577.
30. Rodriguez G, Vitali P, Calvini P, Bordoni C, Girtler N, Taddei G, Mariani G, Nobili F: Hippocampal perfusion in mild cognitive impairment. Psychiatry Res 2000; 100: 65-74.
31. Mosconi L, Mistur R, Switalski R, Tsui WH, Glodzik L, Li Y, Pirraglia E, De Santi S, Reisberg B, Wisniewski T, de Leon MJ: FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's disease. Eur J Nucl Med Mol Imaging 2009; 36: 811-822.
32. de la Torre JC, Fortin T, Saunders J: Correlates between NMR spectroscopy, diffusion weighted imaging and CA1 morphometry following chronic brain ischemia. J Neurosci Res 1995; 41: 238-245.
33. Cada A, de la Torre JC, Gonzalez-Lima F: Chronic cerebrovascular ischemia in aged rats: effects of brain metabolic capacity and behavior. Neurobiol Aging 2000; 21: 225-234.
34. Abdollahian NP, Cada A, Gonzalez-Lima F, de la Torre JC: Cytochrome oxidase: a predictive marker of neurodegeneration; in Gonzalez-Lima F (ed): Cytochrome Oxidase in Neuronal Metabolism and Alzheimer's Disease. New York, Plenum Press, 1998, pp 233-261.
35. de la Torre JC, Aliev G: Inhibition of vascular nitric oxide after rat chronic brain hypoperfusion: spatial memory and immunocytochemical changes. J Cerebral Blood Flow Metab 2005; 25: 663-672.
36. Obrenovich ME, Smith MA, Siedlak SL, Chen SG, de la Torre JC, Perry G: Overexpression of GRK2 in Alzheimer disease and in a chronic hypoperfusion rat model is an early marker of brain mitochondrial lesions. Neurotox Res 2000; 10: 43-56.
37. De Jong GI, Farkas E, Stienstra CM, Plass JR, Keijser JN, de la Torre JC, Luiten PG: Cerebral hypoperfusion yields capillary damage in the hippocampal CA1 area that correlates with spatial memory impairment. Neuroscience 1999; 91: 203-210.
38. Sopala M, Danysz W: Chronic cerebral hypoperfusion in the rat enhances age-related deficits in spatial memory. J Neural Transm 2001; 108: 1445-1456.
39. Farkas E, Luiten PG: Cerebral microvascular pathology in aging and Alzheimer's disease. Prog Neurobiol 2001; 64: 575-611.
40. Ni JW, Matsumoto K, Li HB, Murakami Y, Watanabe H: Neuronal damage and decrease of central acetylcholine level following permanent occlusion of bilateral common carotid arteries in rat. Brain Res 1995; 673: 290-296.
41. Otori T, Katsumata T, Muramatsu H, Kashiwagi F, Katayama Y, Terashi A: Long-term measurements of cerebral blood flow and metabolism in a rat chronic hypoperfusion model. Clin Exp Pharmacol Physiol 2003; 30: 266-272.
42. Tsuchiya M, Sako K, Yura S, Yonemasu Y: Local cerebral glucose utilisation following acute and chronic bilateral carotid artery ligation in Wistar rats: relation to changes in local cerebral blood flow. Exp Brain Res 1993; 95: 1-7. (Pubitemid 23289497)
43. Sekhon LH, Spence I, Morgan MK, Weber NC: Chronic cerebral hypoperfusion inhibits calcium-induced long-term potentiation in rats. Stroke 1997; 28: 1043-1048.
44. Liu HX, Zhang JJ, Zheng P, Zhang Y: Altered expression of MAP-2, GAP-43, and synaptophysin in the hippocampus of rats with chronic cerebral hypoperfusion correlates with cognitive impairment. Brain Res Mol Brain Res 2005; 139: 169-177.
45. Schmitt FA, Davis DG, Wekstein DR, Smith CD, Ashford JW, Markesbery WR: 'Preclinical' AD revisited: neuropathology of cognitively normal older adults. Neurology 2000; 55: 370-376.